MindWave Innovations Signs Two-Year Deal to Build AssureChain for BlockAssure

Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) subsidiary MindWave Innovations Inc. USA has entered a two-year master maintenance and service agreement with BlockAssure Inc. to build, deploy, and operate AssureChain, a dedicated subnet of MindChain tailored for BlockAssure's insurance and reinsurance operations. The agreement, effective October 4, 2026, positions MindWave as BlockAssure's exclusive blockchain provider for AssureChain during the term, with development planned over four quarters. The news, first reported by CryptoCurrencyWire, highlights the growing intersection of blockchain technology and traditional insurance markets.

Under the agreement, MindWave will design, develop, security-audit, and deploy AssureChain, then host, operate, and maintain the network. AssureChain will support contracts, policies, premium and payment entries, reinsurance treaties, and claims processing. MindChain will provide the settlement layer and anchor AssureChain records to Ethereum, ensuring transparency and traceability. In return, MindWave will receive contracted development fees payable in quarterly installments, with operating and maintenance fees to be agreed upon, plus an allocation equal to 20% of the total supply of AssureCoin, a planned digital token within the MindChain network. The agreement will automatically renew for one-year periods after the initial two-year term unless either party provides 90 days' notice.

This collaboration matters because it signals a tangible step toward modernizing insurance and reinsurance infrastructure using blockchain. By integrating blockchain into core insurance processes, AssureChain could reduce friction, enhance data integrity, and streamline claims and treaty management. For Texas, where CryptoCurrencyWire is based, the deal reinforces the state's emerging role as a hub for blockchain innovation and digital asset development. It also demonstrates how publicly traded companies like Apimeds are leveraging subsidiaries to capture value in niche blockchain applications.

The broader implications extend to investors and industry watchers who monitor the adoption of distributed ledger technology in regulated sectors. Successful deployment of AssureChain could serve as a model for other insurers seeking to tokenize assets, automate reinsurance treaties, and improve auditability. MindWave's exclusive provider status and its allocation of AssureCoin align its incentives with the network's long-term success. As blockchain continues to permeate traditional industries, agreements like this one underscore the potential for operational efficiencies and new revenue streams.

For those following Apimeds Pharmaceuticals, the latest updates are available in the company's newsroom. The announcement was distributed through CryptoCurrencyWire, a specialized communications platform focused on blockchain and cryptocurrency. CryptoCurrencyWire is part of the Dynamic Brand Portfolio at IBN, which provides access to a vast network of wire solutions via InvestorWire, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, social media distribution, and a full array of tailored corporate communications solutions. As blockchain adoption accelerates, MindWave's work on AssureChain will be one to watch.